BioCentury
ARTICLE | Financial News

Cytomyx to sell IPO

May 14, 2001 7:00 AM UTC

Drug research company Cytomyx announced plans to sell a 2 million-3 million ($2.8 million-$4.2 million) IPO on the London Stock Exchange's Alternative Investment Market (AIM). Cytomyx ( Cambridge, U.K...